These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 24334974)
21. Atazanavir-containing renal calculi in an HIV-infected patient. Anderson PL; Lichtenstein KA; Gerig NE; Kiser JJ; Bushman LR AIDS; 2007 May; 21(8):1060-2. PubMed ID: 17457108 [No Abstract] [Full Text] [Related]
22. Cardiovascular risk score change in HIV-1-infected patients switched to an atazanavir-based combination antiretroviral regimen. Colafigli M; Di Giambenedetto S; Bracciale L; Tamburrini E; Cauda R; De Luca A HIV Med; 2008 Mar; 9(3):172-9. PubMed ID: 18217998 [TBL] [Abstract][Full Text] [Related]
23. Case presentation: nephrolithiasis in a patient treated with atazanavir. Savini C; James C; Wilson S; Martin H; Szabo S; Scotto V J Assoc Nurses AIDS Care; 2008; 19(3):225-7. PubMed ID: 18457764 [TBL] [Abstract][Full Text] [Related]
24. [Efficacy of atazanavir in simplification regimens]. Zamora L; Gatell JM Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 17():14-21. PubMed ID: 20116612 [TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of replacing lopinavir with atazanavir in HIV-infected patients with undetectable plasma viraemia: final results of the SLOAT trial. Soriano V; García-Gasco P; Vispo E; Ruiz-Sancho A; Blanco F; Martín-Carbonero L; Rodríguez-Novoa S; Morello J; de Mendoza C; Rivas P; Barreiro P; González-Lahoz J J Antimicrob Chemother; 2008 Jan; 61(1):200-5. PubMed ID: 17999977 [TBL] [Abstract][Full Text] [Related]
26. Impact of atazanavir-based HAART regimen on the carotid intima-media thickness of HIV-infected persons: a comparative prospective cohort. de Saint-Martin L; Bressollette L; Perfezou P; Bellein V; Ansart S; Vallet S; Pasquier E AIDS; 2010 Nov; 24(18):2797-801. PubMed ID: 21063175 [TBL] [Abstract][Full Text] [Related]
27. Short communication: UGT1A1*28 variant allele is a predictor of severe hyperbilirubinemia in HIV-infected patients on HAART in southern Brazil. Turatti L; Sprinz E; Lazzaretti RK; Kuhmmer R; Agnes G; Silveira JM; Basso RP; Pinheiro CA; Silveira MF; de Almeida S; Ribeiro JP; Mattevi VS AIDS Res Hum Retroviruses; 2012 Sep; 28(9):1015-8. PubMed ID: 22050734 [TBL] [Abstract][Full Text] [Related]
28. Electrocardiographic changes in HIV-infected, drug-experienced patients being treated with atazanavir. Gianotti N; Guffanti M; Galli L; Margonato A; Chiaravalli G; Bigoloni A; Lazzarin A; Castagna A AIDS; 2007 Jul; 21(12):1648-51. PubMed ID: 17630564 [TBL] [Abstract][Full Text] [Related]
29. Tenofovir discontinuation could predispose to urolithiasis in atazanavir-treated patients. Fabbiani M; Bracciale L; Doino M; D'Avino A; Marzocchetti A; Navarra P; Cauda R; De Luca A; Di Giambenedetto S J Infect; 2011 Apr; 62(4):319-21. PubMed ID: 21329725 [No Abstract] [Full Text] [Related]
30. Clinically significant adverse events from a drug interaction between quetiapine and atazanavir-ritonavir in two patients. Pollack TM; McCoy C; Stead W Pharmacotherapy; 2009 Nov; 29(11):1386-91. PubMed ID: 19857154 [TBL] [Abstract][Full Text] [Related]
31. Severe rhabdomyolysis and acute renal failure secondary to concomitant use of simvastatin, amiodarone, and atazanavir. Schmidt GA; Hoehns JD; Purcell JL; Friedman RL; Elhawi Y J Am Board Fam Med; 2007; 20(4):411-6. PubMed ID: 17615423 [TBL] [Abstract][Full Text] [Related]
32. Prolonged QT interval and torsades de pointes associated with atazanavir therapy. Ly T; Ruiz ME Clin Infect Dis; 2007 Mar; 44(6):e67-8. PubMed ID: 17304444 [TBL] [Abstract][Full Text] [Related]
35. Disappearance of renal stones in an HIV-1-infected patient after reduction of atazanavir dose. Lanzafame M; Bonora S; Lattuada E; Calcagno A; Di Perri G; Concia E AIDS Res Hum Retroviruses; 2014 Sep; 30(9):835-6. PubMed ID: 24998758 [No Abstract] [Full Text] [Related]
36. Efficacy and safety of a switch to unboosted atazanavir in combination with nucleoside analogues in HIV-1-infected patients with virological suppression under antiretroviral therapy. Pavie J; Porcher R; Torti C; Medrano J; Castagna A; Valin N; Rusconi S; Ammassari A; Ghosn J; Delaugerre C; Molina JM; J Antimicrob Chemother; 2011 Oct; 66(10):2372-8. PubMed ID: 21821627 [TBL] [Abstract][Full Text] [Related]